Company Filing History:
Years Active: 2023
Title: Don Corson - Innovator in IRAK Degraders
Introduction
Don Corson is a notable inventor based in East Rutherford, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the modulation of interleukin-1 receptor-associated kinases (IRAK). His work is crucial for developing treatments for various diseases.
Latest Patents
Don Corson holds a patent for "Crystalline forms of IRAK degraders." This patent relates to various forms, salts, and compositions of compounds that are useful for modulating IRAK through ubiquitination and degradation. The implications of this work are substantial, as it opens avenues for treating diseases linked to IRAK.
Career Highlights
Corson is currently associated with Kymera Therapeutics, Inc., where he continues to innovate in the field of therapeutic compounds. His expertise and dedication have positioned him as a valuable asset in the research community.
Collaborations
One of his notable collaborators is Xiaozhang Zheng, with whom he has worked closely on various projects related to IRAK modulation.
Conclusion
Don Corson's contributions to the field of biochemistry, particularly through his patent on IRAK degraders, highlight his role as an influential inventor. His work at Kymera Therapeutics, Inc. continues to pave the way for advancements in medical treatments.